December 23, 2014
RegMed is mired in a fragile week of low volume
December 23, 2014
Tuesday’s RegMed rhythms: Santa needs to deliver sentiment
December 18, 2014
Thursday’s RegMed rhythms: snap, crackle, pop and drop set-up
December 18, 2014
Verastem (VSTM) names new COO
December 18, 2014
Wimslow Estates reports 15% stake in Histogenics (HSGX)
December 17, 2014
RegMed’s boom and busts - weekly
December 17, 2014
Wednesday’s RegMed rhythms: should we drive on a reflated tire with a nail puncture?
December 16, 2014
RegMed, the cheap get cheaper. Where’s The Alliance for Regenerative Medicine (ARM) in support of the sector – when it is MOST needed?
December 16, 2014
Tuesday’s RegMed rhythms: exhausted, confused and anxious
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.